Today: 11 June 2026
D-Wave Quantum (QBTS) stock: Weekend pause after an 8% slide, Wall Street targets, and the next catalysts investors are watching
28 December 2025
4 mins read

D-Wave Quantum (QBTS) stock: Weekend pause after an 8% slide, Wall Street targets, and the next catalysts investors are watching

NEW YORK, Dec. 28, 2025, 4:04 a.m. ET — Market closed (weekend)

D-Wave Quantum Inc. (NYSE: QBTS) heads into the final week of 2025 with U.S. markets shut for the weekend and investors still digesting Friday’s sharp pullback in one of the market’s most volatile “pure-play” quantum computing names. QBTS ended the last regular session at about $25.29, down roughly $2.24 (about 8%) on the day, after trading in a range near $24.78–$27.79 with roughly 33.6 million shares changing hands. MarketBeat+1

The drop came during a muted, post-Christmas session for the broader market. Reuters reported major U.S. indexes finished nearly unchanged on Friday, Dec. 26, in light volume and with few catalysts—conditions that can amplify moves in high-beta, retail-heavy themes like quantum computing.

What happened Friday: a sharp down day in a stock that rarely does “quiet”

MarketBeat’s intraday recap described QBTS as down about 8.2% on Friday, noting the stock traded down to roughly $24.77, while volume was below its recent average—a notable detail in a name that often trades tens of millions of shares per session.

Investor’s Business Daily’s market wrap also flagged D-Wave’s drop of more than 8%, describing the move as part of a volatile stretch after recent gains and highlighting the stock’s wide swings.

No major, company-issued headline hit the tape in the last 48 hours. Instead, the weekend narrative around QBTS has centered on the tug-of-war that defines many quantum stocks right now: real commercial traction and a large cash cushion on one side, and premium valuation plus sharp day-to-day volatility on the other.

The last 24–48 hours of QBTS coverage: downside calls, “10-bagger” talk, and a reality check

Three widely-circulated reads over the past 48 hours captured the split-screen view of D-Wave:

1) “Could QBTS fall to $18?”
Trefis published a note on Dec. 27 arguing the stock could slide further, pointing to a roughly 21% drop in less than a month (from around $32.19 on Dec. 22 to about $25.29) and suggesting $18 “is not out of question” in a deeper correction. Trefis

2) “Next 10-bagger?” (but ‘low-probability’)
Motley Fool contributor Manali Pradhan, CFA wrote late Dec. 27 that D-Wave has standout positioning in quantum annealing commercialization—but argued that a true 10x outcome looks unlikely given today’s valuation and the absence (so far) of a broadly viable, fault-tolerant gate-model system. The Motley Fool

3) A data-driven recap of the slide and Street targets
MarketBeat’s Friday piece emphasized the move’s scale and pulled together current consensus-style figures: a “Moderate Buy” stance and an average price target around $33.67 (as compiled by that outlet). MarketBeat

Fundamentals investors keep circling back to: cash, dilution, and early revenue

One reason D-Wave stays in the conversation—despite the volatility—is the size of its liquidity relative to most early-stage quantum peers.

In its Form 10‑Q for the quarter ended Sept. 30, 2025, D‑Wave reported cash and cash equivalents of $836.2 million (up sharply from year-end 2024). The same filing shows revenue of $3.739 million for the quarter ended Sept. 30, 2025, versus $1.870 million in the prior-year quarter.

But that cash build also came alongside meaningful equity activity. The Sept. 30, 2025 10‑Q reflects substantial financing inflows, including proceeds from at-the-market offerings and other equity-linked activity, and an increased share count versus the prior year-end—facts investors often weigh when thinking about future dilution and per-share economics.

Analyst targets and forecasts: “Buy” ratings, but wide outcomes

Recent Wall Street coverage has generally leaned constructive on D‑Wave—while acknowledging big execution and adoption risk.

  • Jefferies initiated coverage with a Buy and a $45 price target (Dec. 16), pointing to what it described as improving “ecosystem tailwinds,” D‑Wave’s roadmap spanning annealing and gate-model approaches, and a strong balance sheet entering 2026. Investing.com+1
  • Evercore ISI initiated with an Outperform and a $44 target, according to Investor’s Business Daily, with analyst Mark Lipacis emphasizing D‑Wave’s commercial posture and liquidity.
  • MarketBeat’s compilation (as of Friday’s recap) put the average target near $33.67, with a rating mix that still includes at least one bearish view.

The key takeaway for investors: even among bullish initiations, targets vary widely—typical of a frontier tech category where valuation is driven as much by belief in the timeline as by current revenue.

Insider selling: headline risk, but note the trading-plan context

Another topic that tends to flare up around fast-moving stocks: insider activity.

MarketBeat highlighted recent insider sales and linked the transactions to SEC filings, including sales by CEO Dr. Alan Baratz and CFO John Markovich. The filings indicate the transactions were made pursuant to Rule 10b5‑1 trading plans (pre-arranged programs that can reduce the signaling value of an individual sale).

What to watch next: CES, Qubits 2026, and the next earnings window

With the market closed today, investors are likely to look ahead to the next set of potential catalysts rather than weekend price action:

  • CES 2026 / CES Foundry (Jan. 7–8, Las Vegas): D‑Wave says it will participate as a sponsor and showcase customer use cases; executive Murray Thom (VP of quantum technology evangelism) is scheduled to present a masterclass and demo, per the company’s Dec. 22 announcement.
  • Qubits 2026 user conference (Jan. 27–28, Boca Raton): An 8‑K states the event will feature D‑Wave executives and customers and will include updates on its technology roadmap across annealing and gate-model initiatives.
  • U.S. government-focused business unit: In a Dec. 2 8‑K, D‑Wave announced a new unit led by Jack Sears Jr., with CEO Dr. Alan Baratz describing the intent to accelerate quantum applications tied to national security and infrastructure needs.
  • Next earnings timing: MarketBeat lists D‑Wave’s next earnings date as estimated for March 12, 2026 (before market open), noting the company has not confirmed it yet.

If you’re holding (or considering) QBTS: what matters before Monday’s open

Because U.S. equities are closed today, the next real liquidity test comes when trading resumes on Monday, Dec. 29.

A few practical realities matter more for QBTS than for a sleepy blue-chip:

  • Trading hours and liquidity: NYSE Arca’s published schedule shows the early session begins at 4:00 a.m. ET, the core session runs 9:30 a.m.–4:00 p.m. ET, and extended hours run 4:00 p.m.–8:00 p.m. ET—a window where spreads can widen and price moves can be exaggerated.
  • Holiday week mechanics: Investopedia notes stocks trade a full day on New Year’s Eve (Dec. 31), while markets are closed on Jan. 1, 2026 for New Year’s Day—useful context if you’re thinking about liquidity and headline risk around the turn of the year.
  • Volatility regime: Friday’s move reinforced the core reality of quantum pure-plays: QBTS can swing hard even when the broader tape is calm. If Monday brings another thin-volume session, investors often watch whether the stock stabilizes (buyers step in) or whether selling pressure accelerates into year-end positioning.

For now, the weekend state of play is simple: QBTS remains a headline-driven, high-volatility quantum computing stock with real commercial claims and a very large cash position—but one that the market is still learning how to value, sometimes violently, day by day.

Stock Market Today

  • Redwire Stock Rises on $500 Million At-The-Market Share Sale Plan
    June 11, 2026, 10:42 AM EDT. Redwire (RDW) shares climbed Thursday following the announcement of a $500 million at-the-market (ATM) equity program, allowing the company to gradually sell new shares at market prices. The move aims to boost cash for working capital, debt refinancing, acquisitions, and R&D, but introduces dilution risk as existing shareholders' stakes may decrease. Shares opened at $14.88, peaked at $16.26, and last traded at $16.11, up $1.24 from the prior close, with nearly 9.7 million shares changing hands. The new shares could increase the total outstanding from 238.8 million to around 265.8 million, depending on sale prices. Market reaction reflects investor uncertainty about dilution balanced against Redwire's growth funding needs.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Tesla Stock (TSLA) Weekend Update: Robotaxi Deadline, Delivery Forecasts, and Safety Scrutiny in Focus Ahead of Monday’s Open
Previous Story

Tesla Stock (TSLA) Weekend Update: Robotaxi Deadline, Delivery Forecasts, and Safety Scrutiny in Focus Ahead of Monday’s Open

Tesla, Inc. (TSLA) Stock News Today: Robotaxi Pressure-Test, Delivery Forecasts, and What Matters Before Monday’s Open
Next Story

Tesla, Inc. (TSLA) Stock News Today: Robotaxi Pressure-Test, Delivery Forecasts, and What Matters Before Monday’s Open

Go toTop